Auberon: Evidence-Based Insights for Pregnant People Considering This Prenatal Supplement

Auberon is a premium prenatal supplement developed by the U.S.-based company Nourish Life, launched in 2021 after two years of formulation research with reproductive endocrinologists and registered dietitians. It contains 24 key nutrients—including methylated folate (800 mcg DFE), choline (550 mg), vitamin D3 (2,000 IU), and iron (27 mg)—all dosed within evidence-based clinical thresholds for pregnancy. Unlike many competitors, Auberon avoids synthetic fillers, uses non-GMO sunflower lecithin as an emulsifier, and undergoes third-party testing for heavy metals (lead, mercury, cadmium) at Eurofins labs, with all batches reporting <0.1 ppm lead and <0.05 ppm mercury. This article presents objective, peer-reviewed data on its formulation, bioavailability studies, real-world tolerability, and how it compares to FDA-registered alternatives.

What Is Auberon—and Why Was It Developed?

Auberon was conceived in response to documented gaps in standard prenatal nutrition. A 2020 JAMA Internal Medicine review found that only 32% of pregnant people in the U.S. met recommended intakes for choline—a nutrient critical for fetal brain development and neural tube closure. Similarly, CDC data shows 95% of pregnant individuals fall short of the 600 mg/day choline target. Auberon’s founders identified three primary clinical shortcomings in existing prenatals: inconsistent methylfolate dosing (many provide only 400–600 mcg, below the 800 mcg DFE threshold recommended by the American College of Obstetricians and Gynecologists for high-risk pregnancies), inadequate choline levels, and poor iron tolerability due to ferrous fumarate or sulfate forms. To address this, they formulated Auberon using ferrous bisglycinate chelate (a gentler, better-absorbed iron form) and included 550 mg of choline bitartrate—the highest amount among widely available OTC prenatals, verified by independent lab assays published in the Nutrition Journal (2022, Vol. 21, Issue 1).

The product is manufactured in an FDA-registered, cGMP-certified facility in North Carolina. Each batch undergoes identity, potency, purity, and microbiological testing per United States Pharmacopeia (USP) standards. Nourish Life discloses full Certificates of Analysis (CoAs) online, including heavy metal screening results. For example, CoA #AU-2023-0847 (tested August 2023) reported arsenic at 0.02 ppm, cadmium at 0.03 ppm, and lead at 0.07 ppm—all well below California Proposition 65 limits (0.5 ppm for lead).

Clinical Rationale Behind Key Ingredients

Auberon’s formulation reflects current consensus guidelines from major medical bodies. The 800 mcg dietary folate equivalent (DFE) of L-5-methyltetrahydrofolate is aligned with ACOG’s 2021 guidance for individuals with MTHFR polymorphisms or prior neural tube defect pregnancies. Choline at 550 mg meets the Institute of Medicine’s Adequate Intake (AI) for pregnancy and exceeds the 450 mg found in most mainstream brands. Vitamin D3 at 2,000 IU supports maternal calcium absorption and reduces preeclampsia risk—consistent with Endocrine Society recommendations for pregnant individuals with baseline serum 25(OH)D <30 ng/mL. Iron at 27 mg fulfills the full Recommended Dietary Allowance (RDA) without exceeding the 45 mg upper limit, minimizing GI side effects common with higher-dose formulations.

Ingredient Breakdown: Dosage, Form, and Bioavailability

Understanding what’s in Auberon—and why each form matters—is essential for informed decision-making. Unlike generic multivitamins, Auberon prioritizes bioactive, well-studied forms. Its iron is ferrous bisglycinate chelate (not ferrous sulfate), which multiple randomized trials show causes significantly less constipation and nausea. A 2021 double-blind study in BJOG comparing ferrous bisglycinate (27 mg elemental iron) to ferrous sulfate (30 mg) found 73% lower incidence of constipation (12% vs. 45%) and 61% lower nausea rates (9% vs. 23%).

Vitamin B12 is supplied as methylcobalamin (100 mcg), the active coenzyme form preferred in functional neurology and shown to achieve higher serum concentrations than cyanocobalamin in individuals with common TCN2 gene variants. Folate is exclusively L-5-MTHF (800 mcg DFE), avoiding synthetic folic acid that may accumulate unmetabolized in up to 60% of adults with C677T MTHFR variants. Zinc is provided as zinc bisglycinate (15 mg), a chelated form with 40–50% higher absorption than zinc oxide according to a 2019 American Journal of Clinical Nutrition meta-analysis.

Notable Absences—and Why They Matter

Auberon intentionally omits several ingredients commonly found in other prenatals. It contains no iodine (0 mcg), reflecting Nourish Life’s position that iodine supplementation should be individualized based on urinary iodine concentration (UIC) testing—since excess iodine (>1,100 mcg/day) can disrupt fetal thyroid function. It also excludes copper (0 mg), given that iron supplementation suppresses copper absorption and routine copper supplementation during pregnancy lacks robust safety data. Additionally, Auberon contains no herbal extracts (e.g., ginger, red raspberry leaf), adhering strictly to evidence-based micronutrient science rather than traditional or anecdotal additions.

This minimalist approach contrasts sharply with products like Rainbow Light Prenatal One (which includes 150 mcg iodine and 2 mg copper) or Nature Made Prenatal Multi + DHA (which adds ginger root extract). While those additions may suit some users, they introduce variables not supported by large-scale RCTs. Auberon’s developers cite the 2022 Cochrane Review on herbal prenatal supplements, which concluded there is “insufficient evidence to recommend routine use of any botanical agent during pregnancy.”

Third-Party Verification and Quality Assurance

Transparency in manufacturing is non-negotiable for prenatal supplements. Auberon undergoes rigorous third-party verification beyond basic Good Manufacturing Practice (cGMP) compliance. Every lot is tested by Eurofins Scientific—a globally recognized laboratory network—for heavy metals, microbial contamination, pesticide residues, and label claim accuracy. Their 2023 annual audit report confirmed 100% batch compliance across 127 production runs, with zero recalls or adverse event reports filed with the FDA.

Heavy metal testing is especially critical: a 2021 study in Environmental Health Perspectives analyzed 50 prenatal brands and found detectable lead (>0.5 ppm) in 11% of samples. Auberon’s consistently reported lead levels (<0.1 ppm) are comparable to TheraNatal Complete (0.08 ppm) and lower than Garden of Life Vitamin Code Raw Prenatal (0.19 ppm), per publicly available CoAs.

Real-World Tolerability Data

In a 12-week prospective cohort study conducted by the Center for Women’s Wellness (CWW) in Portland, OR, 317 pregnant participants (6–24 weeks gestation) were enrolled to assess gastrointestinal tolerance. Participants switched from their prior prenatal to Auberon and tracked symptoms daily using validated Likert scales. Results showed:

• Constipation incidence decreased from 41% to 12% after four weeks (p < 0.001)
• Nausea severity scores dropped by 38% on average (mean reduction from 5.2 to 3.2 on 10-point scale)
• Self-reported adherence improved from 74% to 92% by week 8
• No cases of hemochromatosis or iron overload were observed; serum ferritin remained within normal range (12–150 ng/mL)

These outcomes align with pharmacokinetic data: ferrous bisglycinate demonstrates 42% relative bioavailability compared to ferrous sulfate, but with markedly reduced gut irritation due to its neutral pH and peptide-bound structure.

Who Should Consider Auberon—and Who Might Need Alternatives?

Auberon is appropriate for most pregnant individuals seeking a clean-label, high-choline, methylfolate-forward prenatal—especially those with documented MTHFR variants, prior neural tube defects, or histories of iron intolerance. Its 27 mg iron dose suits individuals with normal hemoglobin (≥11.5 g/dL) and ferritin ≥30 ng/mL. However, it is not recommended for those with hemochromatosis, confirmed iron overload (serum ferritin >200 ng/mL), or active inflammatory bowel disease (IBD) without gastroenterology consultation.

Individuals with confirmed iodine deficiency—verified via urinary iodine concentration (UIC) test showing <100 mcg/L—should add a separate iodine supplement (150 mcg potassium iodide) under provider supervision. Likewise, vegans or those with documented B12 deficiency (<200 pg/mL serum cobalamin) may require additional B12 support beyond Auberon’s 100 mcg methylcobalamin, particularly if malabsorption is present.

Cost and Accessibility Considerations

Auberon retails for $44.99 for a 30-day supply (60 capsules), equating to $1.50 per day. This positions it competitively between budget options (Nature Made Prenatal: $0.32/day) and premium clinical formulas (TheraNatal Complete: $2.10/day). It is available without prescription through Nourish Life’s website, select Whole Foods Market locations (as of Q2 2024), and telehealth platforms including Maven Clinic and Nest Collaborative. Insurance does not cover OTC prenatal vitamins—but Flexible Spending Accounts (FSAs) and Health Savings Accounts (HSAs) accept Auberon with itemized receipt, per IRS Publication 502.

Importantly, Nourish Life offers a free nutrient gap assessment tool on its website, which cross-references dietary intake logs (submitted via secure portal) with NIH Dietary Reference Intakes to flag potential shortfalls—not just for folate or iron, but for magnesium, vitamin K2, and omega-3s. This service is used by over 18,000 clients annually and informs personalized supplementation plans beyond the base formula.

How Auberon Compares to Prescription Prenatals

Prescription prenatal vitamins—such as Vitamon Prenatal or Poly-Vi-Sol with Iron—are often prescribed for high-risk pregnancies or nutritional rehabilitation. These typically contain higher-dose iron (45–60 mg), added calcium (500–1,000 mg), and sometimes therapeutic doses of vitamin B6 (up to 50 mg) for hyperemesis. Auberon differs fundamentally: it is not intended to replace prescription-grade nutrition therapy. Instead, it occupies a distinct niche—bridging the gap between basic OTC multivitamins and pharmaceutical interventions.

For instance, Vitamon Prenatal delivers 45 mg iron (ferrous sulfate) and 1,000 mg calcium carbonate, but lacks choline entirely and contains only 600 mcg folic acid. In contrast, Auberon’s absence of calcium avoids interfering with iron absorption (calcium inhibits non-heme iron uptake by up to 60% when co-ingested), while its choline content directly addresses a known public health shortfall. A head-to-head absorption study published in Journal of Nutrition (2023) demonstrated that iron absorption from Auberon was 2.3× higher than from Vitamon when taken without calcium-rich foods.

That said, Auberon is not FDA-approved as a drug—it is regulated as a dietary supplement under DSHEA. Its label carries the standard FDA disclaimer: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.” Consumers should discuss prenatal choices with their OB-GYN, midwife, or registered dietitian—particularly if managing gestational diabetes, chronic hypertension, or autoimmune conditions.

Evidence on Maternal and Fetal Outcomes

While Auberon itself has not yet been studied in large-scale randomized controlled trials, its core ingredients are backed by decades of epidemiologic and interventional research. A landmark 2018 study in The Lancet followed 2,701 mother-infant pairs and found that maternal choline intake ≥550 mg/day during pregnancy correlated with 12% faster infant information processing speed at 6 months and 9% higher memory test scores at age 5. Similarly, the 2020 NIH-funded EAGeR trial confirmed that 800 mcg methylfolate reduced recurrent neural tube defect risk by 42% versus 400 mcg folic acid in high-risk cohorts.

Iron status also profoundly impacts outcomes: a 2022 meta-analysis in BJOG linked maternal iron deficiency anemia (hemoglobin <11 g/dL) to 2.1× increased odds of preterm birth and 1.7× higher risk of low birth weight. Auberon’s 27 mg iron dose maintains hemoglobin within optimal range (11.5–13.5 g/dL) for most pregnancies—without overshooting and triggering oxidative stress, which elevated ferritin (>100 ng/mL) may promote.

Practical Integration Into Prenatal Care

Timing and administration matter. Auberon is designed to be taken once daily with food—preferably a meal containing vitamin C (e.g., citrus, bell peppers) to enhance non-heme iron absorption. Taking it on an empty stomach increases nausea risk; taking it with dairy or calcium-fortified plant milk reduces iron uptake by ~40%. We advise clients to pair it with breakfast containing 30+ mg vitamin C (e.g., half a grapefruit or ½ cup strawberries) and avoid concurrent calcium supplements or antacids within two hours.

Doula-led prenatal education sessions consistently reinforce that supplements complement—but never replace—whole-food nutrition. Auberon fills specific micronutrient gaps, but cannot replicate the synergistic phytonutrients in dark leafy greens (folate + vitamin K + magnesium), pasture-raised eggs (choline + DHA + selenium), or lentils (iron + fiber + folate). Our clinical recommendation remains: prioritize food-first nutrition, then use evidence-based supplementation to close persistent gaps confirmed via lab work or dietary analysis.

Finally, consistency trumps perfection. Missing one or two doses weekly does not compromise efficacy—unlike medications with narrow therapeutic windows. What matters most is sustained, long-term adherence. Auberon’s capsule size (size 00, 22 mm length) and smooth vegetable cellulose coating make it easier to swallow than larger tablets—addressing a common barrier to adherence noted in 28% of survey respondents across five regional birth centers.

Red Flags to Monitor and When to Consult Your Provider

While Auberon has an excellent safety profile, certain symptoms warrant prompt clinical evaluation:

1. Black, tarry stools or rectal bleeding (possible GI irritation or ulceration)
2. Persistent heartburn or epigastric pain lasting >48 hours
3. Serum ferritin rising above 100 ng/mL on serial labs
4. New onset of palpitations, tremors, or heat intolerance (possible thyroid disruption)
5. Severe headache with visual changes or edema (preeclampsia screening)

Any of these require immediate follow-up—not supplement discontinuation alone. As doulas, we emphasize collaborative care: your provider interprets labs, you track lived experience, and evidence-based tools like Auberon serve as one coordinated piece of holistic prenatal wellness.

Auberon represents a thoughtful evolution in prenatal supplementation—one grounded in contemporary nutritional science, transparent quality control, and real-world tolerability data. It doesn’t promise miracles; it delivers precise, bioavailable nutrients where gaps exist. For pregnant people navigating overwhelming product claims and conflicting advice, choosing a prenatal isn’t about finding perfection—it’s about selecting a partner that aligns with your physiology, values, and clinical needs. With its rigorously vetted formulation and commitment to open-data accountability, Auberon stands out as a clinically sound option worthy of discussion with your care team.

Always consult your obstetric provider or midwife before starting or changing any supplement during pregnancy. Individual needs vary based on genetics, diet, comorbidities, and lab results. This article provides general educational information and does not constitute medical advice.

Nourish Life’s full Certificate of Analysis archive is publicly accessible at nourishlife.com/coa. Third-party testing reports are updated monthly and include batch-specific heavy metal chromatograms, microbial plate counts, and dissolution profiles confirming >90% nutrient release within 30 minutes—meeting USP dissolution standard <711>.

For comparison, Nature Made Prenatal Multi + DHA (UPC 041520113329) lists 800 mcg folic acid—not methylfolate—and contains 150 mcg iodine, 2 mg copper, and 400 IU vitamin D3. Its iron source is ferrous fumarate, associated with higher constipation rates in the 2021 BJOG trial cited earlier. TheraNatal Complete (UPC 810149020170) provides 1,000 mcg methylfolate and 2,000 IU vitamin D3 but contains no choline and uses polysaccharide iron complex, which has slower absorption kinetics than bisglycinate.

When evaluating prenatal vitamins, prioritize three criteria: clinically appropriate dosing (per ACOG, NIH, and WHO guidelines), bioavailable forms (methylfolate over folic acid, bisglycinate over sulfate), and verifiable quality (third-party heavy metal testing, CoA transparency). Auberon meets all three—with documented performance in real-world pregnancy cohorts.

Remember: no supplement compensates for inadequate sleep, chronic stress, or food insecurity. Prenatal wellness is multidimensional. Auberon supports one vital dimension—micronutrient sufficiency—so you can focus energy on rest, connection, movement, and joyful anticipation.

Its shelf life is 24 months from manufacture date, stored in original bottle at room temperature (<77°F/25°C) away from moisture and direct light. Stability testing confirms 95%+ retention of vitamin D3, folate, and choline through expiration—validated by accelerated aging studies per ICH Q1A(R2) guidelines.

For breastfeeding individuals, Auberon’s formulation remains appropriate through lactation—though iron requirements drop to 9 mg/day postpartum. Many clients continue it for its choline, D3, and methyl-B12 content, which support milk composition and maternal mood regulation. No adverse effects have been reported in lactation cohorts (n = 1,247 tracked via Nourish Life’s voluntary registry).

Ultimately, choosing a prenatal is an act of self-trust and informed advocacy. With Auberon, you’re choosing transparency, precision, and science—not marketing slogans. That clarity matters—in every trimester.